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We performed a ﬂuorescent analysis of the binding of Aβ to the surface membrane of diﬀerent types of cells lines such as PC12,
GT1-7, andex vivo neurons.Analyses were performed on sorted cells with membranebound Aβ Competitive binding between Aβ
phosphatidyl serine- (PtdSer-) speciﬁc binder annexin V and an anti-PtdSer antibody provided compelling data conﬁrming the
involvement of PtdSer as one of the surface membrane signal molecules for Aβ. We found that populations of cells that exhibited
high surface membrane binding aﬃnity for Aβ also show higher membrane cholesterol levels compared to cells that did not bind
Aβ. This direct relationship was upheld in cholesterol-enriched or cholesterol-depleted cell membranes. We conclude that the
initial process for the cell-selective binding by Aβ, to later conversion of elemental Aβ units into larger structures such as ﬁbrils or
to the potentially toxic ion channel aggregates, is highly inﬂuenced by the membrane content of PtdSer and cholesterol in the cell
surface membrane.
1.Introduction
It has been hypothesized that the primary cause for the
cellular damage and the degeneration in the Alzheimer’s
disease (AD) brain is a toxic interaction between the
amyloidogenic peptides amyloid beta peptides (Aβ)a n d
nerve cells [1]. The cellular degeneration observed in the AD
brain is characteristically selective to the neuronal circuits in
the neocortex, hippocampus, and basal forebrain cholinergic
system. Cell selectivity in the toxic Aβ attack is also observed
in vitro within cells in cultures externally exposed to the
peptide Aβ, where not all cells are equally aﬀected by
Aβ and some cells are even found to be resistant. This
selective attack of Aβ to cells in cultures may embody the
selective attack observed in cells of speciﬁc regions of the
AD brain. The peculiarities of these neurons that predispose
them in general to the selective attack of Aβ are not well
understood. However, as the ﬁrst eﬀective interaction of
Aβ with cells occurs at the surface of the cell membrane
[2], observation in cell culture experiments suggests that
the particular aﬃnity of Aβ f o rs p e c i ﬁ cc e l l sr e s i d e si nt h e
composition of the surface membrane. Our earlier ﬁndings
on a variety of neuronal cell lines and ex vivo neurons,
sorted on the basis of aﬃnity to bind Aβ showed that
permanent intracellular and surface membrane conditions
endorsed the initial sensitivity and the association between
Aβ and the cell membrane [3]. The most prominent of the
surface membrane conditions that establish this association
is related to the presence of phosphatidyl serine (PtdSer) on
the outer face of the surface membrane. PtdSer cell surface
exposure is known to serve as a recognition signal during
apoptosis, both for cell removal in apoptosis [4–7]a n d
as a docking site for some proteins [8–10]. Therefore, the
correlation between the presence of PtdSer on the outer face
of the surface membrane and Aβ binding tocells suggests the
PtdSer is a possible docking site for Aβ and deserves further
investigation. The physicochemical interaction of Aβ with
nonprotein components of the plasma membrane, such as
monosialoganglioside GM1 and cholesterol, and with lipid
bilayers of various compositions, has also been a subject2 International Journal of Alzheimer’s Disease
of intense investigation [11–15]. It has been shown that
the ability of Aβ to insert into the membrane is critically
controlled by the ratio of cholesterol to phospholipids
[16]). Altering this ratio, by lowering the concentration of
cholesterol, results in Aβ staying on the membrane surface
region.
Many reports have described the mechanism for Aβ
cytotoxicity as a series of separate processes including Aβ
cell selection and membrane binding [3], incorporation into
membrane [16, 17], and membrane permeabilization [18].
In addition, it has been shown that binding alone is not
suﬃcient for membrane permeabilization [3, 19]. With the
application of ﬂow-cytometry and cell-sorting procedures
in this investigation, we performed a ﬂuorescent analysis
of the binding process of Aβ to the surface membrane
of diﬀerent types of cells lines such as PC12, GT1-7, and
ex vivo neurons. Competitive binding between Aβ and an
anti-PtdSer antibody authenticates the selective binding of
Aβ to surface membrane PtdSer and provided compelling
data conﬁrming the involvement of PtdSer as one of the
surface membrane signal molecules for Aβ.W ef o u n dt h a t
populations of cells that exhibited high Aβ binding aﬃnities
also show higher membrane cholesterol levels compared to
cells that did not bind Aβ. This binding correlation was
conﬁrmed in cholesterol-enriched or cholesterol-depleted
cell membranes. We conclude that the mechanism for Aβ
cytotoxicity involves ﬁrst a cell-selective binding to the cell
surface membrane. This initial process is determined by the
level condition of membrane components of the cell surface
membrane such as PtdSer and cholesterol. The conversion
of elemental units of Aβ into either larger ﬁbrillar structures
or into potentially toxic ion channel Aβ aggregates that will
induce membrane conductance changes requires the initial
binding of Aβ at the surface membrane.
2.Materialsand Methods
2.1. Cell Cultures. The immortalized cell line PC12, derived
from a transplantable rat pheochromocytoma (American
Type Culture Collection, Manassas, VA), immortalized
hypothalamic neurons GT1-7 (provided by Dr. R. Weiner,
University of California at San Francisco), and ex vivo
cultures of hippocampal neurons from newborn rat brains,
weregrowninATCCrecommendedmediaandinneurobasal
medium/B27 (GIBCO), respectively. The preparations of
these ex vivo cultures have been previously described [2, 3].
2.2. Flow Cytometry Analysis, Cell Sorting. To study Aβ
binding and surface membrane, PtdSer cells were incu-
bated in either PBS with 0.3% BSA containing 5μMo f
freshly prepared Aβ42-FAM (ﬂuorescein isothiocyanate) as
recommended by the manufacturer (AnaSpec) for 80min or
annexin V buﬀer with the ﬂuorescence conjugated annexin
V-PE (Phycoerythrin) (Annexin V-PE apoptosis detection
Kit I-BD Bioscience) for 20min. The speciﬁcation from the
manufacturer states that Aβ42-FAM has a purity of >95%
and we conﬁrmed the monomeric state of Aβ in the stock
solutions by polyacrylamide gel analysis. After incubation
cells were washed 3 times and analyzed by ﬂow cytometry
(EPICs XL-MCL Beckman Coulter). Unless speciﬁed in the
text,theﬂowcytometricanalysiswasmadeimmediatelyafter
the very short period of time of exposure to Aβ and to
relatively low concentration of Aβ. Therefore, these condi-
tions are suﬃcient for Aβ binding, but are not suﬃcient to
induce a measurable externalization of PtdSer and apoptosis.
Hence we consider that most detected PtdSer is prior PtdSer
on the surface of the cell membrane. Cells with diﬀerent
Aβ-FAM or annexin V-PE aﬃnity were separated by a
ﬂuorescence-activated cell sorter (FacsAria, BD Biosciences),
bylowpressure(20psi)andlowspeed (1000events/s)[2].To
evaluatecellviability,parallelFACStestswere performedand
the resulting scattergram analyzed. DAPI (4 ,6-diamidino-2-
phenylindole) was also used to ﬂuorescently label cells for
viability analysis in multicolor ﬂow cytometry experiments.
The purity of sorted cell groups routinely exceeded 80–90%
[2].The controlcellswere nottreated with eitherAnnexin V-
PEor Aβ42-FAMbutwere still submittedtothesame sorting
conditions and pooled.
2.3. Changes in the Cell Surface Membrane PtdSer Levels.
To decrease the levels of surface membrane PtdSer on
PC12 cells, we screened the exposed PtdSer by using an
antiphosphatidylserine monoclonal antibody (clone 1H6,
Upstate). For control, we used the corresponding isotype
antibody (Upstate). Based on preliminary experiments, the
ﬁnal antibody concentration in the culture media was
2μg/mL.
2.4. Changes in Membrane Cholesterol Levels. To decrease
the surface membrane, cholesterol content, PC12 cells were
cultured in the presence of 5μM mevastatin (Sigma) for 24
hours and/or treated with 1–16mM methyl-β-cyclodextrin
(CD) (Sigma) for 40 minutes. When cells were cultured
in the presence of mevastatin, Mevalonate (500μM) was
simultaneously added to the culture medium to prevent cell
growth inhibition. To enrich the cholesterol content of the
membrane, cellswere incubated with water-soluble 0.52mM
cholesterol (polyoxyethanyl-cholesteryl sebacate; Sigma) for
2h o u r s .
2.5. Determination of Membrane Cholesterol Levels. To eval-
uate the membrane cholesterol content cells were incu-
bated for 1 hour in PBS containing 400μg/mL Filipin III
(Sigma). Filipin is a polyene antibiotic frequently used as
a probe for quantitative assessment of cholesterol content
[20, 21]. Cells were then 2x washed with ﬁlipin-free PBS
and the membrane-bound ﬁlipin ﬂuorescence was measured
by Fluostar-Optima (BMG-Labtech). Cholesterol content
of cells with diﬀerent Aβ binding aﬃnity was analyzed
immediately after washing oﬀ unbound Aβ-FAM. Cells were
incubated with 100μg/mL of Filipin III for 40 minutes, 2x
washed, and analyzed by ﬂow cytometry (LSRII, BD Bio-
sciences) for Filipin III (355 laser) and Aβ-FAM ﬂuorescence
(488 laser).International Journal of Alzheimer’s Disease 3
2.6. Statistics. When applicable, data are presented as the
mean of ﬁve experiments ± SD. Origin scientiﬁc analysis
software (OriginLab, Northhampton MA) was used to
determine signiﬁcant levels using student’s t-test. The level
of signiﬁcance denoted with double asterisks means highly
signiﬁcant P<. 001 values.
3.Results
3.1. A Remarkable Correlation Is Observed between Aβ
Binding Aﬃnity and the Levels of Surface Phosphatidylserine
in Diﬀerent Types of Cells. We have previously observed that
PC12 cells that exhibit Aβ binding aﬃnity preferentially dis-
play measurable phosphatidylserine (PtdSer) in the surface
membrane [3]. Here we perform a more detailed ﬂuorescent
analysis of this observation in various cell lines including ex
vivo hippocampal neurons and GT1-7 cell line. Annexin V
assay was used as a speciﬁc and standard overall accepted
way for the detection of externalized PtdSer. We followed the
Aβ and annexin V staining protocol previously described [3]
and extended the analysis to diﬀerent degrees of Aβ binding
and to wider range of surface PtdSer levels. We ﬁrst exposed
cells to Aβ-FAM for a short period of time (80min) and
then to annexin V-PE. The results from the ﬂuorescence
analysis, based on levels of intensity of the cell-bound Aβ-
FAM, showed three distinct subpopulations of cells within
all three diﬀerent types of cells. The ﬂuorescence histograms
shown in Figure 1 illustrate these distinct subpopulationsfor
the case of PC12 cells. We have previously reported similar
division of cells into subpopulations in ex vivo hippocampal
neurons and GT1-7 cell line [3]. The cells were classiﬁed into
a subpopulation of cells that did not bind Aβ-FAM (gated
as subpopulation A), a subpopulation of cells that show a
high binding aﬃnity for Aβ-FAM (gated as subpopulation
B), and a subpopulation of cells that show an extra high
binding aﬃnity for Aβ-FAM (gated as subpopulation C).
The results from the ﬂuorescence analysis, based on levels
of intensity of the cell-bound annexin V-PE on each one
of the subpopulations from the three types of cells, are
shown in Figure 2. Cells which displayed surface PtdSer
(annexinV-PEpositive)arewithintherectangleslabeledR.A
remarkablecorrelationwasobservedbetweenthelevelofAβ-
FAMbinding and the levelof surface PtdSer. The tablebelow
shows representative results from the experiment shown in
t h i sﬁ g u r ei nt e r m so ft h ep e r c e n t a g eo fc e l l s( % )a n dt h e
annexin V-PE Geometric-Mean of Fluorescence (GeoMF)
in the gate R. Consistently in all three types of cells, a
signiﬁcantly higher percentage of cells in the subpopulations
Ban dC(highan dv eryhighAβ-FAMbinding) were detected
as PtdSer positive. On the other hand, only a very small
percentageofcellsthatdidnotbindAβ-FAM,subpopulation
A, were detected as PtdSer positive. Similar results were
consistentlyobservedinthreeadditionalexperiments.Notice
thatall PC12and GT1-7 cellswith extrahighbindingaﬃnity
for Aβ-FAM (gated as subpopulation C) are within the
rectangles labeled R. Additionally, the annexin V-PE GeoMF
for these cells presented values ten times higher compared to
cells gated as subpopulation B.
3.2. Aβ-FAM Binding on Cells Sorted on the Basis of Annexin
V-PE Binding. Sorted PS+ Cells Displayed the Highest Binding
Aﬃnity for Aβ-FAM. The correlation between Aβ-FAM
binding and surface PtdSer observed in the ﬂow cytometric
data shown in Figure 1 was also observed with ﬂuorescence-
activated cell sorting. PC12 Cells were exposed to annexin
V-PE, as described in Material and Methods. The annexin
V-PE levels of ﬂuorescence histograms shown in Figure 3(a)
clearly group the cells into well-deﬁned PtdSer negative
(PS−) and PtdSer positive (PS+) cell groups. The rectangles
in the ﬁgures specify the limits of ﬂuorescence characterizing
the groups. The numbers in the ﬁgure are the averaged
percentage PS− and PS+ cells from four experiments. This
ﬂuorescent analysis shows that almost one third of the cells
(32 ± 3.5%) are PS+. This ﬁnding allows for ﬂuorescence-
activated cell sorting based on annexin V-PE binding to
separate subpopulations of cells with distinct binding char-
acteristics.
We then examined sorted PS− and PS+ groups of cells
for Aβ-FAM binding aﬃnities. Sorted PS− and PS+ groups
and control PC12 cells were exposed to Aβ-FAM within 2
hours after sorting. The results from ﬂowcytometric analysis
of the sorted groups of cells exposed to Aβ-FAM are shown
superimposed in Figure 3(b). The highest percentage of cells
binding Aβ-FAM (88%, R1g a t e ,A β-FAM positive cells) was
f o u n di nt h eg r o u po fs o r t e dP S + cells.
3.3. Speciﬁc Antibody to PtdSer Reduces the Number of Surface
Membrane Binding Sites Available for Aβ-FAM Binding. To
study the inﬂuence of the levels of PtdSer molecules on
the surface of the membrane on the magnitude of Aβ-FAM
binding to the cell surface, an antibody that speciﬁcally
binds to PtdSer (anti-PS mAb) was used. PC12 cells were
ﬁrst treated with anti-PS monoclonal antibody and then
exposed to annexin V-PE for PtdSer identiﬁcation and to
Aβ-FAM to study Aβ binding. In previous experiments with
artiﬁcial membranes and with cells in culture, we showed
that Aβ42-FAM behaves in the same way as native Aβ,s i n c e
it forms ion channels and induces the same toxic eﬀects
on cells to the one induced by native Aβ.F u r t h e r m o r e ,
all these manifestation of Aβ42-FAM are prevented by
the speciﬁc Aβ channel blockers [22–24]. Therefore, we
considered it safe and appropriate to use Aβ42-FAM to
study Aβ membrane binding. The R2 gate, annexin V-
PE positive cells, in the multigraph Figure 4(a),s h o w st h a t
before the anti-PS antibody treatment, 38% of cells were
detected by annexin V-PE as PS+. When cells were pre-
treated with the anti-PS antibody, the percentage of PS+
cells detected by annexin V-PE was reduced to 22%. This
represents a 42% reduction in the number of detectable
PS+ cells. Our previous experiments suggest that both the
anti-PS antibody and Aβ-FAM preferentially bind to PS+
cells. Therefore, it will be expected that after a combined
treatment the number of PS+ cells detected by annexin V-
PE will be considerably more reduced. This is observed in
the multigraph Figure 4(b) that shows the number of PS+
cells after exposing cells to Aβ-FAM alone and to anti-PS
antibody followed by Aβ-FAM. Although 38% of PS+ for4 International Journal of Alzheimer’s Disease
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Figure 1: Fluorescence analysis of Aβ-FAM binding on PC12 cells. PC12 cells were exposed to Aβ-FAM for a short period of time (80min).
Based on the levels of intensity of bound Aβ-FAM cells are grouped into three distinct subpopulations: a population of cells that did not
bind Aβ (subpopulation A), a population of cells that show a high binding aﬃnity for Aβ (subpopulation B), and a population of cells that
show an extra high binding aﬃnity for Aβ (subpopulation C). Fluorescence analysisshowed that approximately 62% of all PC12 cells in the
culture were classiﬁed as Aβ positive (Aβ+).
untreated PC12 cells is high compared to other cell lines, we
attempted to artiﬁcially increase this percentage in order to
make it easier to observe the reducing eﬀect of the PtdSer
antibody. In these experiments, the time of exposure to Aβ-
FAM was extended to six hrs in order to allow Aβ-FAM to
increase theinitial percentageofPS+ c e l l s .W eh a v ed e s c ri b e d
before that one of the early eﬀects of Aβ in cells is to increase
the externalization of PS [2]. Exposure to Aβ-FAM for six
hrs is longer when compared to the short exposure time,
80 and 120min, used in the experiments shown in Figures
1 and 2, but still not too long to jeopardize the viability of
cells [2]. The R2 gate, annexin V-PE positive cells, in the
multigraphFigure 4(b)shows that after cells were exposed to
Aβ-FAM alone, 80% of cells were detected by annexin V-PE
as PS+. This percentage is considerably higher than the 38%
observed in untreated cells (Figure 4(a)). When cells were
ﬁrst treated with the anti-PS antibody and then with Aβ-
FAM, the percentage of PS+ cells detected by annexin V-PE
was noteworthy reduced from 80% to 59%, indicating a 26%
change. The analysis based on Aβ-FAM binding illustrates
that the cell binding of Aβ-FAM was also reduced by the
treatment with the anti-PS antibody. The R1g a t e ,A β-FAM
positive cells, in the multigraph Figure 4(c) shows that after
cells were exposed for six hours to Aβ-FAM, 96% of cells
were detected as Aβ+ cells. However, when cells were treated
with the anti-PS antibody before exposed to Aβ-FAM, the
percentage ofAβ+ cells was reduced to 61%. Altogetherthese
results demonstrate that treating cells with anti-PS antibody
reducesthelevelofdetectablesurfacePtdSerandalsoreduces
the number of surface membrane binding sites for Aβ-FAM.
3.4. Flow Cytometric Analysis Shows a Correlation between
the Binding of Aβ-FAM to the Surface Membrane and the
Levels of Cholesterol within the Membrane. Since cholesterol
is the most abundant sterol associated with phospholipids in
cell membranes, we studied any possible correlationbetween
the levels of membrane cholesterol and Aβ-FAM surface
membrane binding. We followed both Aβ-FAM ﬂuorescence
and cholesterol indicator Filipin III staining protocols to
simultaneously evaluate Aβ-FAM binding and surface mem-
brane cholesterol. The immortalized cell line PC12 cells were
incubated ﬁrst for 80 minutes in PBS containing Aβ42-FAM,
washed from unbound Aβ42-FAM, and then incubated for
40 minutes in PBS containing Filipin III. The percentage of
cells binding Aβ-FAM and the levels of surface membrane
cholesterol were obtained from ﬂow cytometric analysis of
the ﬂuorescence from Aβ-FAM and Filipin bound to cells,
respectively. Similarly as shown in the histograms described
in Figure 1, ﬂow cytometric analysis of the ﬂuorescence
from Aβ-FAMdistinguished threedistinct subpopulationsof
PC12 cells. The analysis of the cholesterol content of these
subpopulations based on Filipin III ﬂuorescence is shown in
Figure 5(a). A remarkable correlation was observed between
the level of Aβ-FAM binding and the level of membrane
cholesterol. The highest level of ﬁlipin III ﬂuorescence is
observed in the cells from the subpopulationdeﬁned as extra
high Aβ-FAM aﬃnity (C). To quantify the results, cells were
counted within the M gate which was deﬁned to include
a majority of cells with the highest ﬁlipin III ﬂuorescence.
The table shows the results from the experiment shown in
Figure 5(a) in terms of the percentage of cells (%) and the
ﬁlipin III Geometric-Mean of Fluorescence (GeoMF) in theInternational Journal of Alzheimer’s Disease 5
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Figure 2: Correlation between Aβ-FAM binding and the levels of surface phosphatidylserine in diﬀerent types of cells. Hippocampal
neurons, PC12, and GT1-7 cells were double ﬂuorescence labeled with Aβ-FAM and annexin V-PE. The histograms show ﬂuorescence
analysis from the three types of cells based on levels of intensity of the cell-bound annexin V-PE of each one of the subpopulations as
deﬁned in Figure 1. There is a remarkable correlation between the level of Aβ-FAM binding and the level of PtdSer. The table below shows
representative results in terms of the percentage of cells (%) and the annexin V-PE Geometric-Mean of Fluorescence (GeoMF) in the gate R.
gate M.T h ee x t r ah i g hA β42-FAM aﬃnity subpopulations
of cells showed 4 times higher GMF values as compared to
cellswith no Aβ42-FAMaﬃnity. The bars plot in Figure 5(b)
summarizes the percentage of cells and the GMF values
within gate M corresponding to each subpopulation. The
data in this ﬁgure are the pooled results obtained from
four experiments. The data compellingly show a correlation
between the levels of cholesterol in the membrane and the
binding of Aβ-FAM to the surface.
3.5. Fluorescence-Activated Cell Sorting Based on Aβ-FAM
Fluorescence Conﬁrms the Correlation of the Levels of Aβ
Binding tothe MembraneSurface withthe Levels of Cholesterol
within the Membrane. The correlation between Aβ-FAM
binding and the levels of membrane cholesterol observed6 International Journal of Alzheimer’s Disease
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Figure 3: Correlation between Aβ-FAM binding and surface PtdSer observed on cells sorted on the basis of annexin V-PE binding. PC12
cells were exposed to annexin V-PE for 20min, and sorted based on the levels of annexin V-PE binding. The histograms in (a) show the
results of the distribution of the cells. The numbers in the ﬁgures are the averaged percentage of PtdSer− and PtdSer+ cells from four
sorting experiments. The resulting groups of cells, untreated control, PtdSer+,a n dP t d S e r − were then treated with Aβ-FAM. (b) shows the
ﬂuorescence histograms on the basis of Aβ-FAM binding. The results of cell count in the R1g a t e ,A β-FAM positive cells, show that the
PtdSer+ group of cells has the highest percentage (88%) of cells with bound Aβ.
in the ﬂow cytometric analysis of Aβ-FAM and Filipin
bound to cells shown in Figure 5 was also observed in
ﬂuorescence-activated cell sorting experiments. PC12 cell
andhippocampal neuronalcellswere exposed for80minutes
to Aβ-FAM for binding and then sorted on the basis of the
FAM ﬂuorescence. Sorted cells were cultured and allowed
to grow for eight days. Membrane cholesterol levels were
measured at 1 and at 8 days after sorting. The bar plots
in Figures 6(a) and 6(b) show the results for the PC12 cell
and hippocampal neuronal cells, respectively. Cells sorted
for their high Aβ-FAM aﬃnity have a higher membrane
cholesterol level compared to cells with no aﬃnity for Aβ-
FAM. The correlation between Aβ-FAM binding and the
membrane cholesterol level, measured right after cells were
exposed to Aβ-FAM (Figure 5), is also observed 1 and 8
days after cell sorting. Our experiments in these two types
of cells show that eight days after cell sorting, the diﬀerential
cholesterolleveland thediﬀerentiallevelofAβ-FAMbinding
[3] in the two subpopulation are also sustained.
3.6. A Linear Correlation between Aβ-FAM Binding to the
Surface Membrane and the Levels of Cholesterol within
the Membrane Persists over a Wide Range of Membrane
Cholesterol. ThecorrelationbetweenAβ-FAMbindingtothe
surface of the membrane and the levels of cholesterol in
the membrane was tested over a wide range of membrane
cholesterol. The content of cholesterol in the membrane was
artiﬁcially changed following previously used experimental
procedures. To decrease the level of membrane cholesterol,
cells were exposed to methyl-β-cyclodextrin (CD) and to
the HMG-CoA reductase inhibitor mevastatin. These two
procedures have been successfully used to reduce cholesterol
from the surface membrane of cultured cells [21–25]. CD
eﬃciently extracts cholesterol from the surface membrane
of cultured cells, and mevastatin inhibits the de novo
synthesis of cholesterol consequently reducing the content
of cholesterol in the plasma membrane. The combined
inhibition of HMG-CoA reductase, followed by moderate
cell exposure to CD, has also been found to produce aInternational Journal of Alzheimer’s Disease 7
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Figure 4: Speciﬁc antibody to PtdSer reduces the number of surface membrane binding sites for Aβ-FAM. PC12 cells were exposed for
20min to annexin V-PE, for PtdSer identiﬁcation, and for 6hrs to Aβ-FAM to study Aβ-FAM binding before and after treatment with
anti-PtdSer monoclonal antibody (Anti PtdSer mAb). The ﬂuorescence histograms in (a) show that cells treated with anti-PtdSer mAb
reduced the percentage of PtdSer+ cells in gate R2by 42%oftheuntreated value. The ﬂuorescence histogramsin (b) showthatthe combined
treatment of anti-PtdSer mAb and Aβ-FAM reduced the percentage of PtdSer+ cells in gate R2 by 26% of the value observed after treatment
with Aβ-FAM alone. The ﬂuorescence histograms in (c) show that Aβ-FAM binding, measured as Aβ+ cells in R1, is also reduced, by 36%,
when cells are pretreated with anti-PtdSer mAb. The tables in each panel show the percentage of PtdSer+ and Aβ+ cells in gates R2a n dR1,
respectively and Δ% represents the percentage of the change.
signiﬁcant reduction in cellular membrane cholesterol on
PC12 cells [26]. Hence, to reduce the levels of cholesterol
in the surface membrane, PC12 cells were exposed to
media containing (CD), mevastatin, or a combination of
both. To increase the cholesterol content of the surface
membrane, cells were incubated in media enriched with
soluble cholesterol which is directly taken up by the cell
membrane [26].
The histograms shown in Figure 7(a) show the
distribution of cells based on the Aβ-FAM ﬂuorescence8 International Journal of Alzheimer’s Disease
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Figure 5: Correlation between the levels of cholesterol in the membrane and the binding of Aβ- F A Mt ot h em e m b r a n es u r f a c e .P C 1 2c e l l s
were exposed for 80 minutes to Aβ42-FAM, washed to remove unbound Aβ-FAM, and then incubated for 40 minutes in PBS containing
Filipin III. (a) shows the ﬂow cytometric analysis of the cholesterol content of the three subpopulations of cells distinguished on the bases
of the level of Aβ-FAM binding. The percentage of cells and the Geo mean of ﬂuorescence (GeoMF) values measured within the M gate are
displayed in the bottom table. The highest level of ﬁlipin III ﬂuorescence is observed in the cells from the subpopulation C, deﬁned as extra
high Aβ-FAM aﬃnity. The bars plot in (b) summarizes the percentage of cells and the GMF values within gate M corresponding to each
subpopulation of data pooled from four experiments.
from PC12 cells treated with diﬀerent concentrations of
CD. PC12 cells were exposed for 40 minutes to media
containing CD. Then, cells were exposed for 80 minutes
to CD-free Aβ-FAM-containing medium. The ﬂuorescence
f r o mt h em e m b r a n eb o u n dA β-FAM was evaluated by ﬂow
cytometry. As the extraction of cholesterol is increased by
exposing cells to media with increasing concentrations of
CD, 1–16mM, the percentage of Aβ+ cells was gradually
reduced from 82% in normal medium to 42% after treated
with 16mM of CD. The histograms in Figure 7(b) show the
distribution of the cells based on the Aβ-FAM ﬂuorescence
from PC12 cells treated with mevastatin and mevastatin
plus CD. PC12 cells were cultured in the presence of
5μM mevastatin for 24 hours and then exposed for 80
minutes to either mevastatin-free Aβ-FAM-containing
medium or mevastatin-Aβ-FAM-containing medium.
In one condition, 4mM CD was added for 40 minutes to
the mevastatin-containing media before the media wasInternational Journal of Alzheimer’s Disease 9
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Figure 6: Correlation between Aβ-FAM binding and the levels of membranecholesterol observed in cells sorted on the basis of the Aβ-FAM
ﬂuorescence. PC12 cell and hippocampal neuronal cells were exposed for 80 minutes to Aβ- F A Mf o rb i n d i n ga n dt h e ns o r t e do nt h eb a s i s
of the FAM ﬂuorescence. After sorting Aβ-FAM, treated cells were pooled into two populations: no Aβ-FAM aﬃnity and Aβ-FAM aﬃnity.
Cells were cultured and allowed to grow and membrane cholesterol levels were measured at 1 and at 8 days after sorting. (a) and (b) show
the results for the PC12 cell and hippocampal neuronal cells, respectively. The correlation between the levels of Aβ-FAM binding and the
levels of membrane cholesterol is observed even after 8 days of cell sorting.
replaced by mevastatin-Aβ-FAM-containing medium.
When cells were cultured in the presence of mevastatin,
mevalonate (500μM) was simultaneously added to the
culture medium to prevent cell growth inhibition. The
histograms show that the percentage of Aβ+ cells was
reduced from 59% in untreated conditions to 42 and
27% when treated with mevastatin. The combination of
procedures was more eﬃcient than the application of the
each procedure separately. The percentage of Aβ+ cells
within gate R was further reduced to 17%. The histograms
in Figure 7(c) show the distribution of the cells based on
the Aβ-FAM ﬂuorescence from cells incubated in media
enriched with soluble cholesterol. PC12 cells were incubated
with water-soluble 0.52mM cholesterol (polyoxyethanyl-
cholesteryl sebacate) for 2 hours. Then, cells were exposed
for 80 minutes to Aβ-FAM-containing medium, and the
ﬂuorescence from the membrane bound Aβ-FAM was
evaluated by ﬂow cytometry. The histograms show that
enriching the cell surface membrane with cholesterol, the
percentage of Aβ+ cells increases from 50%, cells incubated
in normal medium, to 68% when cells are incubated in
cholesterol-enriched medium.
To examine the correlation linking Aβ-FAM binding
to the surface membrane with membrane cholesterol over
an extended range of cholesterol levels in the mem-
brane, the values from ﬂow cytometric analysis of the
ﬂuorescence from Filipin, recorded at the time when
membrane-bound Aβ-FAM was measured, are plotted in
Figure 7(d). The plot compiles the percentages, relative
to control, of Aβ+ cells and cholesterol membrane levels
which were obtained from the application of the diﬀerent
experimental procedures altering the levels of cholesterol in
the surface membrane. Linear regression analysis to the data
reveals that within the resulting range of cholesterol levels
there is a rather good linear relationship (R = 0.93977)
between membrane cholesterol levels and Aβ membrane
binding.
4.Discussion
In previous investigations, we showed that a ﬁrm binding
of Aβ to the cell membrane is ﬁrst required for Aβ to
initiate a toxic eﬀect [2, 3]. We showed that Aβ is also
speciﬁcally selective in binding just to deﬁne subpopulations
of the cells in culture [3]. A sensible rationale based on
these two pieces of information is to attribute the Aβ cell
selectivity to the characteristic binding properties of cells.
Consequently, surface membrane signal molecules are going
to play an important part in assisting Aβ to achieve one
of its most notorious fateful roles. Here we performed
ﬂuorescent analyses of the binding of Aβ-FAM to the surface
membrane of diﬀerent types of cells lines such as PC12,
GT1-7, and ex vivo neurons and studied the inﬂuence of
the natural membrane component PS and cholesterol on
that cell-selective binding. Flow cytometric analyses were
made on unsorted cells and on populations of cells that
were previously sorted on the basis of their level of bound
ﬂuorescent Aβ-FAM or ﬂuorescent annexin V. We artiﬁcially
modiﬁed the levels of the natural membrane components PS
and Cholesterol to study the inﬂuence of these components
on the magnitude of the binding of Aβ-FAM to the cell
surface membrane. The data presented here revealed that,
within a wide range of cholesterol and PS levels, the10 International Journal of Alzheimer’s Disease
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Figure 7: Correlation between Aβ-FAM binding and the levels of cholesterol in the membrane over a wide range of membrane cholesterol.
To vary the levels of cholesterol in the cell membrane, PC12 cells were treated with diﬀerent concentrations of methyl-β-cyclodextrin (CD)
(a),mevastatin(M), (b) and polyoxyethanyl-cholesteryl sebacate (Cholesterol) (c). Then, cells were exposed for 80 minutes to Aβ-FAM and
the ﬂuorescence from the membrane bound Aβ-FAM was evaluated by ﬂow cytometry. The percentage of cells in gate R (numbers in the
ﬁgures) shows that enriching or depleting the cell membrane of cholesterol increases or reduces the levels of Aβ-FAM binding to the surface
of the membrane. The plot in (d) compiles the percentage of Aβ+ cells as a function of the level of cholesterol in the membrane recorded at
the time when membrane-bound Aβ-FAM was measured. The straight line is the result of a linear relation ﬁt of data (R = 0.93977).
membrane content of these components shows a striking
direct linear correlation with the capacity of the surface
membrane to bind Aβ-FAM. Because many reports have
demonstrated that the Aβ toxicity on cells increases at low
membrane cholesterol and high surface PS levels, the data
presented here enforces the concept that binding and toxic
cell-damaging interactions of Aβ with the cell membrane
are two distinct events, and the extent of either one of
these events is modulated by the relative concentrations
of the membrane components. The requirements for Aβ
molecules to bind to membranes seem to be independent
of the structural conﬁguration required to make Aβ a
toxic molecule [27]. Aβ peptides possess a strong surface
activity that makes them to prefer to stay in an amphiphilic
environment such as the membrane surface region. Aβ may
bind to membranes as nontoxic monomers as well as toxic
small aggregates. All the experiments described here were
initiated after the addition to the media of fresh prepared
Aβ-FAM. Therefore, cells in our experiments were exposed
indiscriminately to monomers and diﬀerent aggregated Aβ-
FAM forms, since Aβ-FAM starts to aggregate immediately
after it is placed in solution and timely adopt diﬀerent
conﬁgurations. It was not the objective of this investigation
t od i s c e r ni nw h i c hw a yt h es t a g eo fa g g r e g a t i o no fA β-
FAM may aﬀect its binding to cell membranes; however,
we are conscious that monomers and oligomers may aﬀect
diﬀerently the organization of some membrane components
such as cholesterol [28].
We have previously observed that Aβ binding is not
always associated with Aβ toxicity, although we have shown
that Aβ toxicity is essentially preceded by Aβ binding [2].
Other reports have shown that the lipid membrane is not
perturbed until the peptide Aβ penetrates the membrane.
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this penetration happens the Aβ peptides intercalate deeply
into the lipid bilayer changing the physical properties of
the membrane [26]. Aβ can also change the membrane
ﬂuidity [29, 30], destabilizing the membrane and inducing
membrane fusion [31]. We have shown that when appro-
priate oligomeric structures of Aβ are located within the
membrane, it results in selective changes in the membrane
ionic conductance allowing destabilizing ionic inﬂuxes [18,
32]. Under the experimental conditions executed in this
investigation, relatively low concentration and very short
period of time of exposure to Aβ-FAM, cells remain
apparently unaﬀected up to several days (Figure 5 and [3]);
consequently, we think that the results obtained in this work
can be interpreted as mainly to reﬂect the eﬀect of some
membrane components on the initial event, that is, the Aβ
binding to the surface membrane.
This investigation corroborates our previous reports that
distinctive cell characteristics, some of them residing in the
cellsurface membrane, favorAβbindingtoselectivecultured
neuronalsubpopulations[3].Whethercellswere exposed for
binding to Aβ-FAM or to annexin V-PE, the results of the
ﬂuorescentanalysisonthediﬀerentcelltypesshowedthatthe
cell culturesdid not consist of homogeneous cell population,
butinstead consistedof subpopulationsofcells characterized
by diﬀerential levels of a common target for Aβ and for
annexin V binding. Analysis of these binding characteristics
reveals a consistent correlation between Aβ-FAM binding
and annexin V-PE binding, suggesting a common binding
target. We also observed that the correlation between these
binding properties is not only present when cells were
sorted, but also persists for days after both growth and
several cell divisions cycles have occurred. We interpret
this observation to be conclusive evidence that the speciﬁc
binding properties are permanent resident characteristic of
certain cell subpopulations, thereby providing an explana-
tion for the speciﬁc cell sensitivity to Aβ bindings and the
selective toxicity observed in cultured cells. The annexin V
assay is used as a speciﬁc and standard, accepted overall
for the detection of the externalized acidic phospholipid
PtdSer. Therefore, the binding correlation observed in this
investigationstrongly supportstheproposedideathatPtdSer
is the commonmembrane surface bindingtarget for annexin
Va n df o rA β-FAM. Using a diﬀerent experimental approach
that evaluates cell viability, we had previously shown that
annexin V protects against Aβ-peptide toxicity, and based
on PtdSer liposome aggregation assays we have suggested
that the mechanisms by which Aβ and annexin V bind the
surface of the cell membrane were by competitive binding
to a common site in the apoptotic signal molecule PtdSer
[33]. The ﬂuorescent analysis performed here shows that
when studying Aβ and annexin V binding to cultured cells
it is possible to ﬁnd that Aβ-FAM positive neurons can be
also annexin V positive. The information obtained from
the experimental approach in this investigation with cells
in culture is not suﬃcient to question the competitive
binding to a common site observed in PtdSer liposome
aggregation. The simultaneous binding of Aβ-FAM and
annexin V observed in cells could be explained on the basis
of unoccupied binding sites still present in the cells after Aβ
exposure. This is expected based on a dynamic competition
between these two ligands for a common site (viz, PS).
We have previously reported a progressive increase in cell
ﬂuorescence which increases with the concentration and the
time of exposure to ﬂuorescent Aβ [3]. By contrast, details
of the annexin V binding with phospholipids have not yet
been studied with the same level of detail, and no speciﬁc
binding site has been identiﬁed for either head groups or
lipid acyl chain. Conceivably, binding sites may be created
by speciﬁc conformational changes. On the other hand, it is
generally accepted that the Aβ-membrane interaction which
precedes the insertion in the membrane occurs by a speciﬁc
electrostatic interaction of Aβ with acidic phospholipids of
negativelychargemembranes.Therefore,theresultsreported
here suggest that the negatively charged lipid, PtdSer, is
required to establish an eﬀective Aβ-lipid interaction.
Further support for this idea is that acidic phospholipids
stabilize Aβ into an α-helical conformation via electrostatic
interaction with the negatively charged membrane interface,
thus stabilizing Aβ membrane binding [34]. The striking
correlation between the Aβ-FAM aﬃnity and the PtdSer-
speciﬁc annexin V binding observed in the diﬀerent types
of cells studied in this work therefore strongly supports the
hypothesis proposed from artiﬁcial liposome aggregation
experiments which describes the acidic phospholipid PtdSer
as a possible receptor for Aβ [33].
In addition to PtdSer, other factors or other membrane
components are known to additionally facilitate Aβ binding
to membranes [13, 14]. Numerous reports have suggested
other cell membrane components, such as monosialogan-
glioside GM1 and cholesterol, as facilitators of the functional
interaction of Aβ with cell membranes [12, 14–16, 24, 35].
It is proposed that Aβ selectively recognizes ganglioside-
clustered, raft-like membrane microdomains in membranes,
and binds to and accumulates on the GM1-rich domains
in a time- and concentration-dependent manner. Allegedly,
this speciﬁc binding to ganglioside results in the alteration of
Aβ secondary structure, leading to the formation of amyloid
ﬁbrils [15, 35]. The assembly of higher Aβ aggregates to
the formation of amyloid ﬁbrils in these microdomains has
been subjected to intense studies [12, 13, 35–37]w h i c h
suggest that lipid molecules in the surface membrane,
such as cholesterol and sphingomyelin, are involved in the
process [12, 15]. The ﬂuorescent analysis performed in this
investigation reveals the positive impact of the concentration
of cholesterol in the membrane on the extent of Aβ binding
to the membrane surface region. Experiments with cells
containing diﬀerent membrane cholesterol levels, achieved
by artiﬁcially enriching or reducing the cholesterol in the
membrane, clearly showed that the amount of Aβ-FAM
bound on the surface of the membrane linearly correlates
with the amount of cholesterol within the membrane.
Therefore, theassertion thatcholesterol mediatesAβbinding
applies within a wide range of cholesterol concentrations
and applies also to various cell types. Cholesterol plays
a multifaceted role when it is added to cells in culture,
thus an explanation for the correlation with the surface
membrane binding of Aβ is more intricate. Cholesterol may
interact with Aβ itself and aﬀects Aβ conformational state,12 International Journal of Alzheimer’s Disease
it facilitates the clustering of gangliosides that binds Aβ,a s
well as it alters the physical-chemical properties of neuronal
membranes, including membrane ﬂuidity and membrane
lipiddynamics. Some reports aﬃrm thatcholesterol not only
contributes to Aβ binding to the surface of the membrane,
but the ability of Aβ to insert into the membrane is critically
controlled by the ratio of cholesterol to phospholipids [16].
Cholesterol tends to adopt energetically favorable domains
in membranes, thus cholesterol domain formation may be
actively involved in modulating the interaction of Aβ with
lipid bilayers [28]. These diverse of actions of cholesterol
therefore have consequences on Aβ membrane binding as
well as Aβ membrane insertion. When in aqueous solution
Aβ adopts a random-coil conformation; but when reacting
with cholesterol-containing vesicles Aβ undergoes confor-
mational changes that facilitates Aβ binding or insertion into
the membrane [16]. When Aβ displays a signiﬁcant popula-
tionof β-structures, it is basically surface associated, whereas
when it is α-helix structured it is most likely transmembrane
incorporated [34]. Therefore, the cholesterol modulation of
the two separate events that result from the cell’s exposure to
Aβ, that is, binding and insertion into the membrane [2, 19],
is related to its membrane concentration levels. Because
cholesterol aﬀects Aβ structure, the membrane components
organization, and the membrane physical properties, the
results from our ﬂuorescent analysis of cells exposed to Aβ-
FAM suggest that as cholesterol concentration increases the
Aβ membrane binding event is favored and Aβ insertion
event is prevented. This is in accordance with a series
of previous reports that point out that there is a strong
dependence of Aβ insertion and the Aβ channel activity as a
function of the cholesterol content of the surface membrane
[31, 38–40] .W e ,a n do t h e r s ,h a v ea l s os h o w nt h a ti n s e r t i o n
that creates toxic membrane perturbations and cell death is
favored as membrane cholesterol levels decrease [25, 37].
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